[1] Yates RA,Nanney LB,Gates RE,et al.Epidermal growth factor and related growth factors. Int J Ikrmatol,1991, 30:687.
[2] Payrastre B,Bergen en Henegouwen PMPV,Breton M,etal. Phosphoinositide kinase, diacylglycerol kinase and phospholipase C activities associated to the cytoskeleton,effect of epidermal growth factor. J Cell Biol, 1991,115:121.
[3] Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem,1990,265:7709.
[4] Falanga V, Tiegs SL, Alstadt SP, et al. Transforming growth factor-beta,elective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol, 1987, 89:100.
[5] Asaga H,Kikuchi S,Yoshizato K. Collagen gel contraction by fibroblasts requires cullular fibronectin but not plasma fibronectin. Exp Cell Res,1991,193:167.
[6] Priestley GC. Skin fibroblast monolayers; a suitable case for treatment? In:Marks R eds. Skin models-models to study function and diseases of skin. Germany:Springer,1986:292~304.
[7] Mazzone T, Pustelnikas L. Growth-related modulation of human skin fibroblast cholesterol distribution and metabolism. Biochem Biophys Acta,1990,1047:180.
[8] Pal S, Davis PJ N-3 polyunsaturated fatty acids enhance cholesterol efflux from human fibroblasts in culture. Biochem Biophys Res Commun,1990,173:566.
[9] Datubo-Brown DD, Blight A. Inhibition of human fibroblast growth in vitro by a snake oil. Br J Plast Surg,1990,43:183.
[10] Elder JT, Fisher GJ, Duell EA, et al. Regulation of keratinocyte growth and differentiation; interactive signal transduction.pathways. In; Goldsmith LA ed. Physiology, biochemistry, and molecular biology of the skin. NY:Oxford,1991:266. |